Patents by Inventor Diana Koletzki

Diana Koletzki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING DRUG RESISTANCE MUTATIONS IN ANY OF THE NON-STRUCTURAL PROTEIN REGIONS NS3 TO NS5B OF HEPATITIS C VIRUS (HCV) FOR GENOTYPES 1 TO 6
    Publication number: 20160177407
    Abstract: The present invention relates to a method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6, more in particular for subtype specific genotypes 1a, 1b, 2a, 2b, 3a, 4a and 4d.
    Type: Application
    Filed: December 22, 2014
    Publication date: June 23, 2016
    Inventors: Diana Koletzki, Jan Martin Berke, Ina Isabel Vandenbroucke, Leen Roger Vijgen
  • Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
    Patent number: 8945833
    Abstract: The present invention relates to a method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6, more in particular for subtype specific genotypes 1a, 1b, 2a, 2b, 3a, 4a and 4d.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: February 3, 2015
    Inventors: Lieven Jozef Stuyver, Diana Koletzki, Jan Martin Berke, Ina Isabel Vandenbroucke, Leen Roger Vijgen
  • METHOD FOR DETERMINING DRUG RESISTANCE MUTATIONS IN ANY OF THE NON-STRUCTURAL PROTEIN REGIONS NS3 TO NS5B OF HEPATITIS C VIRUS (HCV) FOR GENOTYPES 1 TO 6
    Publication number: 20110189684
    Abstract: The present invention relates to a method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6, more in particular for subtype specific genotypes 1a, 1b, 2a, 2b, 3a, 4a and 4d.
    Type: Application
    Filed: October 6, 2009
    Publication date: August 4, 2011
    Inventors: Lieven Jozef Stuyver, Diana Koletzki, Jan Martin Berke, Ina Isabel Vandenbroucke, Leen Roger Vijgen
  • Substituted thiophenes
    Publication number: 20070099929
    Abstract: The invention relates to substituted thiophenes and processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular for hepatitis C viruses.
    Type: Application
    Filed: June 16, 2006
    Publication date: May 3, 2007
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Kai Thede, Tobias Wunberg, Timothy Lowinger, Diana Koletzki, Andreas Urban, Judith Baumeister, Kerstin Henninger
  • Medicaments for viral diseases
    Publication number: 20020082264
    Abstract: Chromanone derivatives are highly active antiviral agents. Combinations of chromanones and/or chromanols with HBV polymerase inhibitors, HBV DNA inhibitors or HBV core protein inhibitors and/or isoxazoles and, where appropriate, interferon inhibit the replication of HBV viruses better than agents disclosed previously.
    Type: Application
    Filed: August 30, 2001
    Publication date: June 27, 2002
    Inventors: Susanne Nikolic, Stephan Bartel, Michael Brands, Ulrich Niewohner, Arnold Paessens, Erwin Graef, Karl-Heinz Schlemmer, Kerstin Henninger, Rainer Endermann, Olaf Weber, Diana Koletzki